RobertMartinGrantMD

PubMed

• Non-B variants of HIV-1 in San Francisco, California.
  Kara J. O'Keefe, Sharon Pipkin, Robin Fatch, Susan Scheer, Teri Liegler, Willi McFarland, Robert M. Grant, Hong-Ha M. Truong> ;Infection, Genetics and Evolution. 2021 Jun 1
• 4 citations
  Use of Drug-level Testing and Single-genome Sequencing to Unravel a Case of Human Immunodeficiency Virus Seroconversion on Pre-exposure Prophylaxis.
  Matthew A Spinelli, Brentton Lowery, Jennifer A Shuford, Jon Spindler, Mary F. Kearney, Jenny McFarlane, Cheryl McDonald, Hideaki Okochi, Nhi Phung, Karen Kuncze, Kath...> ;Clinical Infectious Diseases. 2021 Jun 1
• 9 citations
  HIV preexposure prophylaxis with tenofovir disoproxil fumarate/emtricitabine and changes in kidney function and tubular health.
  Simon B. Ascher, Rebecca Scherzer, Michelle M. Estrella, Judy K. Shigenaga, Kimberly A. Spaulding, David V. Glidden, Megha Mehrotra, Patricia Defechereux, Monica Gandh...> ;AIDS. 2020 Apr 1
• 35 citations
  Acquisition of tenofovir-susceptible, emtricitabine-resistant HIV despite high adherence to daily pre-exposure prophylaxis: a case report.
  Stephanie E. Cohen, Darpun Sachdev, Sulggi A. Lee, Susan Scheer, Oliver Bacon, Miao-Jung Chen, Hideaki Okochi, Peter L. Anderson, Mary F. Kearney, Susa Coffey, Hyman M...> ;The Lancet. HIV. 2019 Jan 1
• Identification of Hepatitis B virus genotype I in Thailand.
  Holzmayer, V.,Hance, R.,Defechereux, P.,Grant, R.,Kuhns, M. C.,Cloherty, G.,Rodgers, M. A.> ;J. Med. Virol.. 2018 Oct 24
• "Losing the Phobia:" Understanding How HIV Pre-exposure Prophylaxis Facilitates Bridging the Serodivide Among Men Who Have Sex With Men.
  Koester, K. A.,Erguera, X. A.,Kang Dufour, M. S.,Udoh, I.,Burack, J. H.,Grant, R. M.,Myers, J. J.> ;Front Public Health. 2018 Sep 22
• Acquisition of Multidrug-Resistant Human Immunodeficiency Virus Type 1 Infection in a Patient Taking Preexposure Prophylaxis.
  Colby, D. J.,Kroon, E.,Sacdalan, C.,Gandhi, M.,Grant, R. M.,Phanuphak, P.,Ananworanich, J.,Robb, M. L.,Phanuphak, N.> ;Clin. Infect. Dis.. 2018 Jul 03
• 30 citations
  The Role of Social Relationships in PrEP Uptake and Use Among Transgender Women and Men Who Have Sex with Men
  Megha Mehrotra, K. Rivet Amico, Vanessa McMahan, David V. Glidden, Patricia Defechereux, Juan V. Guanira, Robert M. Grant> ;AIDS and Behavior. 2018 Nov 1
• Characterization of HIV Recent Infection Among High-Risk Men at Public STI Clinics in Mumbai
  Christina P Lindan, Robert M Grant> ;AIDS and Behavior. 2018 Feb 18
• 60 citations
  Association of age, baseline kidney function, and medication exposure with declines in creatinine clearance on pre-exposure prophylaxis: an observational cohort study.
  Monica Gandhi, David V. Glidden, Kenneth H. Mayer, Mauro Schechter, Susan Buchbinder, Beatriz Grinsztejn, Sybil G. Hosek, Martin Casapia, Juan V. Guanira, Linda-Gail B...> ;The Lancet. HIV. 2016 Nov 1
• Transgender Women in Clinical Trials of Pre-Exposure Prophylaxis.
  Grant RM, Sevelius JM, Guanira JV, Aguilar JV, Chariyalertsak S, Deutsch MB> ;J. Acquir. Immune Defic. Syndr.. 2016-08-15
• 32 citations
  Depression and Oral FTC/TDF Pre-exposure Prophylaxis (PrEP) Among Men and Transgender Women Who Have Sex With Men (MSM/TGW).
  Patricia Defechereux, Megha Mehrotra, Albert Liu, Vanessa McMahan, David V. Glidden, Kenneth H. Mayer, Lorena Vargas, K. Rivet Amico, Piotr Chodacki, Telmo Fernandez, ...> ;AIDS and Behavior. 2016 Jul 1
• Brief Report: HIV-1 gp120 T-Cell Responses Correspond to Infection Outcomes in the Global iPrEx Chemoprophylaxis Trial.
  Kuebler PJ, Shaw BI, Leadabrand KS, Mehrotra ML, Grant RM, Kallás EG, Nixon DF> ;J. Acquir. Immune Defic. Syndr.. 2016-06-01
• Symptoms, Side Effects and Adherence in the iPrEx Open-Label Extension.
  Glidden DV, Amico KR, Liu AY, Hosek SG, Anderson PL, Buchbinder SP, McMahan V, Mayer KH, David B, Schechter M, Grinsztejn B, Guanira J, Grant RM> ;Clin. Infect. Dis.. 2016-05-01
• 24 citations
  Elevations in Serum Creatinine With Tenofovir-Based HIV Pre-Exposure Prophylaxis: A Meta-Analysis of Randomized Placebo-Controlled Trials.
  Rabi Yacoub, Girish N. Nadkarni, Damian Weikum, Ioannis Konstantinidis, Anna Boueilh, Robert M. Grant, Kenneth K. Mugwanya, Jared M. Baeten, Christina M. Wyatt> ;Journal of Acquired Immune Deficiency Syndromes. 2016 Apr 1
• The Safety of Tenofovir-Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B.
  Solomon MM, Schechter M, Liu AY, McManhan VM, Guanira JV, Hance RJ, Chariyalertsak S, Mayer KH, Grant RM> ;J. Acquir. Immune Defic. Syndr.. 2016-03-01
• Persistent HIV Type 1 Seronegative Status Is Associated With Lower CD8+ T-Cell Activation.
  Kuebler PJ, Mehrotra ML, Shaw BI, Leadabrand KS, Milush JM, York VA, Defechereux P, Grant RM, Kallás EG, Nixon DF> ;J. Infect. Dis.. 2016-02-15
• 190 citations
  HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial
  Madeline B. Deutsch, David V. Glidden, Jae Sevelius, JoAnne Keatley, Vanessa McMahan, Juan V. Guanira, Esper G. Kallas, Suwat Chariyalertsak, Robert M. Grant> ;The Lancet. HIV. 2015 Dec 1
• Editorial Commentary: Keeping Our Eyes on the Prize: No New HIV Infections With Increased Use of HIV Pre-exposure Prophylaxis.
  Koester KA, Grant RM> ;Clin. Infect. Dis.. 2015-11-15
• Strong Correlation Between Concentrations of Tenofovir (TFV) Emtricitabine (FTC) in Hair and TFV Diphosphate and FTC Triphosphate in Dried Blood Spots in the iPrEx Ope...
  Gandhi M, Glidden DV, Liu A, Anderson PL, Horng H, Defechereux P, Guanira JV, Grinsztejn B, Chariyalertsak S, Bekker L, Grant RM> ;J. Infect. Dis.. 2015-11-01
• Brief Report: Recent Infection, Sexually Transmitted Infections, and Transmission Clusters Frequently Observed Among Persons Newly Diagnosed With HIV in San Francisco.
  Truong HM, Pipkin S, OʼKeefe KJ, Louie B, Liegler T, McFarland W, Grant RM, Bernstein K, Scheer S> ;J. Acquir. Immune Defic. Syndr.. 2015-08-15
• Effects of Emtricitabine/Tenofovir on Bone Mineral Density in HIV-Negative Persons in a Randomized, Double-Blind, Placebo-Controlled Trial.
  Mulligan K, Glidden DV, Anderson PL, Liu A, McMahan V, Gonzales P, Ramirez-Cardich ME, Namwongprom S, Chodacki P, de Mendonca LMC, Wang F, Lama JR, Chariyalertsak S, G...> ;Clin. Infect. Dis.. 2015-08-15
• Weighing the risk of drug resistance with the benefits of HIV preexposure prophylaxis.
  Grant RM, Liegler T> ;J. Infect. Dis.. 2015-04-15
• Reply to Boyd et al.
  Solomon MM, Mayer KH, Glidden DV, Guanira JV, Grant RM> ;Clin. Infect. Dis.. 2015-01-15
• Streamlining HIV testing for HIV preexposure prophylaxis.
  Guanira JV, Leigler T, Kallas E, Schechter M, Sharma U, Glidden D, Grant RM> ;J. Clin. Microbiol.. 2015-01-01
• Join now to see all